Inhibition of IκB Kinase-β Protects Dopamine Neurons Against Lipopolysaccharide-Induced Neurotoxicity

Parkinson's disease (PD) is a progressive neurological disorder characterized by a selective loss of dopamine (DA) neurons in the substantia nigra (SN). Although current therapy can control symptoms of this disorder, there is no effective therapy available to halt its progression. Recently, neu...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Zhang, Feng, Qian, Li, Flood, Patrick M., Shi, Jing-Shan, Hong, Jau-Shyong, Gao, Hui-Ming
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The American Society for Pharmacology and Experimental Therapeutics 2010
Gaiak:
Neuropharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2879929/
https://ncbi.nlm.nih.gov/pubmed/20190013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.110.165829
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak